Ishares Msci Italy ETF vs GeneDx Holdings Corp — how do they compare? Ishares Msci Italy ETF trades at $63.12, while GeneDx Holdings Corp trades at $82.2 (market cap $2.45B). The key difference: Ishares Msci Italy ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| EWI | WGS | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $63.35 | $167.51 |
52-Week Low | $50.31 | $34.51 |
Market Cap | — | $2.45B |
Enterprise Value | — | $2.49B |
Signals from Pluang's Aura AI — not financial advice
EWI trades at $63.18, up 0.02% today, with a bullish technical signal from moving averages but overbought RSI readings. The stock recently hit a 52-week high, driven by positive European market sentiment and Italy's economic recovery narrative. A dividend of $1.17 is scheduled for June 2026, offering income potential.
Outlook is cautiously optimistic given strong technical momentum and favorable European equity flows, but risks include ECB policy shifts and energy price volatility. Investors should weigh technical overbought conditions against fundamental growth prospects in Italy's market.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Trailing returns across standard periods
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →